Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2026-04-21
Summary
Background:
The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormone cortisol. Too much cortisol in the body causes Cushing disease. This disease causes many problems. Some of these problems might persist after the disease is cured.
Objective:
To find out the long-term effects of exposure to high levels of cortisol during childhood and adolescence.
Eligibility:
People ages 10-42years who were diagnosed with Cushing disease before age 21 and are now cured and have normal or low cortisol levels
People related to someone with Cushing disease
Design:
Participants will be screened with a medical history.
Participants will complete an online survey. This will include questions about their or their child s physical and mental health.
All participants will be seen at 5 -year intervals after cure of Cushing disease (5yr, 10yr, 15yr, 20yr (last visit))
Participants who have a relative with Cushing disease will have a medical history and blood tests or cheek swabs.
Participants who have the disease will have:
Physical exam
Blood tests
Cheek swab
DXA scan: A machine will x-ray the participant s body to measure bone mineral content.
For participants who are still growing, a hand x-ray
Participants with the disease may also have:
Hormone stimulation test: Participants will get a hormone or another substance that will be measured.
Serial hormone sampling: Participants blood will be measured several times through a thin plastic tube in an arm vein.
Urine tests: Participants urine may be collected over 24 hours.
MRI: Participants may have a dye injected into a vein. They will lie on a table that slides into a machine. The machine will take pictures of the body.
Conditions
- Cushing Disease
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Deborah P Merke, M.D. · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility
- Min Age
- 2 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-04
- Primary Completion
- 2040-01-03
- Completion
- 2040-01-03
Countries
- United States
Study Locations
More Related Trials
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
NCT03379363 ·Status: TERMINATED
-
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
NCT00796783 ·Status: TERMINATED
-
Endocrine Studies of Healthy Children
NCT00001195 ·Status: COMPLETED
-
Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283 ·Status: TERMINATED
-
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT02804750 ·Status: COMPLETED ·Phase: PHASE2
-
Cushing's Syndrome Before and After Treatment (CORRECT)
NCT05521529 ·Status: RECRUITING
-
DDAVP for Pituitary Adenoma
NCT04569591 ·Status: RECRUITING ·Phase: NA
-
Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004334 ·Status: UNKNOWN
-
Mifepristone in Children With Refractory Cushing's Disease
NCT01925092 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 ·Status: UNKNOWN
-
Cushing's Disease Complications
NCT02568982 ·Status: COMPLETED
-
The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
NCT02791698 ·Status: UNKNOWN
-
The Factors Associated With the Recurrence in Patients With Cushing Disease
NCT02233335 ·Status: COMPLETED
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
NCT00682084 ·Status: TERMINATED
-
Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
NCT00171951 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
NCT00001180 ·Status: COMPLETED
-
Treatment for Endogenous Cushing's Syndrome
NCT01838551 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
NCT01859312 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
NCT00422201 ·Status: TERMINATED ·Phase: PHASE2
-
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
NCT03760835 ·Status: RECRUITING ·Phase: PHASE4
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
NCT01915303 ·Status: TERMINATED ·Phase: PHASE2